Zoetis | ZTS - Umlaufvermögen

Aktienkurs
116.87
Täglich Wechseln
0.81 0.70%
Monatlich
0.14%
Jährlich
-23.85%
Q2 Prognose
114.37




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Bayer EUR 32.91B 30M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Charles River Laboratories USD 1.45B 85.06M 2025-12
Coherus Biosciences USD 206.71M 254.25M 2025-12
Dentsply International USD 2.02B 49M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Henry Schein USD 4.46B 69M 2025-12
Idexx Laboratories USD 1.41B 63.23M 2025-12
Illumina USD 3.29B 493M 2025-12
IQVIA Holdings USD 6.25B 270M 2025-12
J&J USD 59.17B 3.55B 2026-03
Laboratory Of America USD 4.02B 58.3M 2025-12
Merck USD 47.56B 10.49B 2025-09
Neogen USD 590M 15.42M 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Quest Diagnostics USD 2.57B 188M 2026-03
Sanofi EUR 30.16B 789M 2026-03
Sanofi EUR 30.95B 8.99B 2025-12
Zoetis USD 6.77B 185M 2025-12